BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kowalczyk T, Kisluk J, Pietrowska K, Godzien J, Kozlowski M, Reszeć J, Sierko E, Naumnik W, Mróz R, Moniuszko M, Kretowski A, Niklinski J, Ciborowski M. The Ability of Metabolomics to Discriminate Non-Small-Cell Lung Cancer Subtypes Depends on the Stage of the Disease and the Type of Material Studied. Cancers (Basel) 2021;13:3314. [PMID: 34282765 DOI: 10.3390/cancers13133314] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Ding J, Feng Y. Mass spectrometry-based metabolomics for clinical study: Recent progresses and applications. TrAC Trends in Analytical Chemistry 2022. [DOI: 10.1016/j.trac.2022.116896] [Reference Citation Analysis]
2 Lackner M, Neef SK, Winter S, Beer-hammer S, Nürnberg B, Schwab M, Hofmann U, Haag M. Untargeted stable isotope-resolved metabolomics to assess the effect of PI3Kβ inhibition on metabolic pathway activities in a PTEN null breast cancer cell line. Front Mol Biosci 2022;9:1004602. [DOI: 10.3389/fmolb.2022.1004602] [Reference Citation Analysis]
3 López-lópez Á, Ciborowski M, Niklinski J, Barbas C, López-gonzálvez Á. Optimization of capillary electrophoresis coupled to negative mode electrospray ionization-mass spectrometry using polyvinyl alcohol coated capillaries. Application to a study on non-small cell lung cancer. Analytica Chimica Acta 2022;1226:340259. [DOI: 10.1016/j.aca.2022.340259] [Reference Citation Analysis]
4 Yan C, Wu D, Gan L, Wang J, Yang W, Xu B. Significant metabolic alterations in non-small cell lung cancer patients by epidermal growth factor receptor-targeted therapy and PD-1/PD-L1 immunotherapy. Front Pharmacol 2022;13:949745. [DOI: 10.3389/fphar.2022.949745] [Reference Citation Analysis]
5 Liang L, Hu M, Chen Y, Liu L, Wu L, Hang C, Luo X, Xu X. Metabolomics of bronchoalveolar lavage in children with persistent wheezing. Respir Res 2022;23:161. [PMID: 35718784 DOI: 10.1186/s12931-022-02087-6] [Reference Citation Analysis]
6 Mariën H, Derveaux E, Vanhove K, Adriaensens P, Thomeer M, Mesotten L. Changes in Metabolism as a Diagnostic Tool for Lung Cancer: Systematic Review. Metabolites 2022;12:545. [PMID: 35736478 DOI: 10.3390/metabo12060545] [Reference Citation Analysis]
7 Haince JF, Joubert P, Bach H, Ahmed Bux R, Tappia PS, Ramjiawan B. Metabolomic Fingerprinting for the Detection of Early-Stage Lung Cancer: From the Genome to the Metabolome. Int J Mol Sci 2022;23:1215. [PMID: 35163138 DOI: 10.3390/ijms23031215] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]